Retrospective study on MRI accuracy in assessing liver fibrosis among patients with chronic liver disease.

IF 1.9
Bioinformation Pub Date : 2025-06-30 eCollection Date: 2025-01-01 DOI:10.6026/973206300211643
Subha Santhoshi Vanka, Nikita Rao Nalla, Shaheed Shaik, Navneeth Jayaprakash, Mohammed Zakiullah Shareef, Sneha Mahalpure
{"title":"Retrospective study on MRI accuracy in assessing liver fibrosis among patients with chronic liver disease.","authors":"Subha Santhoshi Vanka, Nikita Rao Nalla, Shaheed Shaik, Navneeth Jayaprakash, Mohammed Zakiullah Shareef, Sneha Mahalpure","doi":"10.6026/973206300211643","DOIUrl":null,"url":null,"abstract":"<p><p>Magnetic resonance imaging (MRI) is increasingly being utilized for the non-invasive liver fibrosis evaluation among chronic liver disease (CLD) patients. Therefore, it is of interest to assess the staging and diagnostic accuracy of MRI for liver fibrosis compared to histopathological outcome in 150 patients with CLD. MRI data were analyzed with advanced techniques such as elastography and T1/T2 mapping and these results were matched against fibrosis stages ascertained through biopsy. The sensitivity and specificity of MRI in detecting extensive fibrosis ≥F2 were 88% and 91%, respectively. Fibrosis scores determined by MRI were correlated with histopathological stage with r = 0.87, p < 0.01. The findings revealed MRI as an effective non-invasive modality for liver fibrosis that, complementarily, decreases the position of invasive biopsy in patients with CLD.</p>","PeriodicalId":8962,"journal":{"name":"Bioinformation","volume":"21 6","pages":"1643-1646"},"PeriodicalIF":1.9000,"publicationDate":"2025-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12449564/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioinformation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.6026/973206300211643","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Magnetic resonance imaging (MRI) is increasingly being utilized for the non-invasive liver fibrosis evaluation among chronic liver disease (CLD) patients. Therefore, it is of interest to assess the staging and diagnostic accuracy of MRI for liver fibrosis compared to histopathological outcome in 150 patients with CLD. MRI data were analyzed with advanced techniques such as elastography and T1/T2 mapping and these results were matched against fibrosis stages ascertained through biopsy. The sensitivity and specificity of MRI in detecting extensive fibrosis ≥F2 were 88% and 91%, respectively. Fibrosis scores determined by MRI were correlated with histopathological stage with r = 0.87, p < 0.01. The findings revealed MRI as an effective non-invasive modality for liver fibrosis that, complementarily, decreases the position of invasive biopsy in patients with CLD.

MRI评估慢性肝病患者肝纤维化准确性的回顾性研究。
磁共振成像(MRI)越来越多地被用于慢性肝病(CLD)患者的非侵入性肝纤维化评估。因此,比较150例CLD患者的组织病理学结果,评估MRI对肝纤维化的分期和诊断准确性是有意义的。采用弹性成像和T1/T2成像等先进技术分析MRI数据,并将这些结果与活检确定的纤维化分期相匹配。MRI检测广泛纤维化≥F2的敏感性和特异性分别为88%和91%。MRI纤维化评分与组织病理分期相关,r = 0.87, p < 0.01。研究结果显示,MRI是一种有效的肝纤维化非侵入性检查方式,并且可以减少CLD患者侵入性活检的位置。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Bioinformation
Bioinformation MATHEMATICAL & COMPUTATIONAL BIOLOGY-
自引率
0.00%
发文量
128
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信